This is to Inform you that at the Meeting of the Board of Directors of the Company held today on Tuesday, 15th April 2025 It has further informed that all final call is called up on ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries informed the stock exchange that at its board meeting held on April 15, 2025, it approved the conversion of warrants into equity shares on a preferential basis. The final call money on these warrants was called up on April 8, 2025, making them fully paid up. A total of 25 crore (25,00,00,000) equity shares were allotted to three non-promoter companies — Parichay Infrastructure Ltd (8.20 crore shares), Rama Shiva Lease Finance Pvt Ltd (8.40 crore shares), and Interface Financial Services Ltd (8.40 crore shares). This marks the completion of a previously announced preferential allotment of warrants.
Shareholders should note significant potential dilution as 25 crore new equity shares have been allotted, which will increase the total share base. The stock price may face short-term pressure due to dilution, though the funds were already anticipated from the earlier warrant issue. Existing investors now hold a smaller proportional stake in the company.